Acromegaly
📧 Sign up to get email alerts when something new happens for Acromegaly.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Strict IGF-1 Control in Acromegaly [Phase 3]
Phase 3 clinical trial evaluating strict IGF-1 control in acromegaly has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: A Pilot Study of Pre- and Post-operative Use of Somatuline Depot. [Phase 4]
A Phase 4 pilot trial evaluating pre- and post-operative use of Somatuline Depot was terminated; results posted in 2021 for acromegaly.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly [Phase 2]
An extension study reports long-term safety and efficacy data for pasireotide in acromegaly participants (Phase 2), completed with results p…
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Programme of Acromegaly Screening in Patients With Associated Somatic Disorders
Completed clinical trial evaluating acromegaly screening in patients with associated somatic disorders; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly [Phase 3]
Phase 3 clinical trial update evaluating efficacy and safety of Octreotide capsules (MYCAPSSA) for acromegaly.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic Patients [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of lanreotide autogel at 60, 90, or 120 mg in patients with acromegaly has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues [Phase 3]
Phase 3 trial evaluating pasireotide in patients with acromegaly inadequately controlled by first-generation somatostatin analogues has comp…
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly [Phase 3]
A Phase 3 clinical trial evaluated 120 mg Somatuline Autogel given at 28, 42, or 56 day intervals in patients with acromegaly.
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism [Phase 2]
Phase 2 trial assessing efficacy and safety of pasireotide LAR in Japanese patients with acromegaly or pituitary gigantism has been complete…
-
CLINICAL_TRIALS trial_result · 2019-08-16Clinical Trial Update: Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR [Phase 4]
Phase 4 trial assessing lanreotide Autogel in acromegaly patients previously treated with octreotide LAR has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: Somatuline Autogel: Acromegaly Self/Partner Injection Study [Phase 4]
Phase 4 clinical trial update on Somatuline Autogel for acromegaly; study completed.
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly [Phase 2, Phase 3]
Phase 2/3 trial update evaluating varying doses of Lanreotide Autogel for acromegaly, focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT) [NA]
Clinical trial update on growth hormone feedback to IGF-1 and OGTT in adults with acromegaly and type 2 diabetes mellitus; the study is comp…
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly [Phase 4]
A Phase 4 clinical trial completed in 2019 evaluating management of pasireotide-induced hyperglycemia in adults with Cushing's disease or ac…
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Clomiphene Citrate for Treatment of Acromegaly [Phase 2]
Phase 2 clinical trial evaluating clomiphene citrate for acromegaly has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-29Clinical Trial Update: Acromegaly Treatment Quality of Life Study
A completed clinical trial assessing quality of life in acromegaly treatment, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-25Clinical Trial Update: Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly [Phase 1, Phase 2]
Phase 1/2 trial assessing maximum tolerated dose, safety, and tolerability of a single-dose lanreotide prolonged-release formulation in adul…
-
CLINICAL_TRIALS trial_result · 2019-03-08Clinical Trial Update: Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly [Phase 2]
Phase 2 clinical trial of BIM23B065 given as repeated subcutaneous injections in subjects with acromegaly; the study is terminated with resu…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan
Clinical trial update reporting long-term use of pegvisomant (Somavert) for acromegaly as part of a regulatory post-marketing commitment; st…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With Acromegaly [Phase 3]
Phase 3 trial update reporting efficacy and tolerability of lanreotide (Autogel 120 mg) in acromegaly.
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly [Phase 3]
Phase 3 trial evaluating the efficacy and safety of co-administered lanreotide Autogel at 60/90/120 mg with lanreotide prolonged-release 40 …
-
CLINICAL_TRIALS trial_result · 2018-09-11Clinical Trial Update: Ultrasound Guided Octreotide LAR Injection in Acromegaly [Phase 4]
Phase 4 clinical trial update on ultrasound-guided Octreotide LAR injections for acromegaly; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients [Phase 3]
Phase 3 clinical trial evaluating combination therapy with lanreotide Autogel and pegvisomant in acromegaly has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly
This clinical trial update reports on ectopic lipid deposition and insulin resistance after treatment of acromegaly.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics [Phase 2]
Phase 2 trial evaluating subcutaneous infusions of three doses of DG3173 on growth hormone levels in untreated acromegaly patients is comple…